![Craig Collard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Collard
Directeur Général chez
HERON THERAPEUTICS, INC.
Fortune : 1 M $ au 30/06/2026
Profil
Craig A. Collard was the founder of Carolina Pharmaceuticals, Inc., founded in 2003, serving as President & Chief Executive Officer.
Mr. Collard was the founder of Cornerstone BioPharma, Inc., founded in 2004, serving as Chief Financial Officer from 2010 to 2011.
Mr. Collard was the founder of Chiesi USA, Inc., founded in 2008, serving as Chairman & Chief Executive Officer from 2008 to 2014.
Current jobs include Chief Executive Officer & Director at Heron Therapeutics, Inc. since 2023; Director at BioMarck Pharmaceuticals Ltd.; Director-Triangle Chapter at Cystic Fibrosis Foundation; Director at Hilltop Home Foundation; and Lead Independent Director at Terrascend Corp.
since 2018.
Former jobs include President & Chief Executive Officer at Critical Therapeutics, Inc.; President, Chief Executive Officer & Director at Cornerstone Biopharma Holdings, Inc. from 2004 to 2008; President & Chief Executive Officer at Veloxis Pharmaceuticals A from 2015 to 2021; Chief Executive Officer & Director at Veloxis Pharmaceuticals, Inc. from 2015 to 2021; Chairman at Opiant Pharmaceuticals, Inc. from 2021 to 2023; Independent Director at Sierra Oncology, Inc. from 2020 to 2022; Director-National Accounts at DJ Pharma, Inc. from 1998 to 2002; Principal at Dura Pharmaceuticals, Inc.; and Vice President-Sales at Verum Pharmaceuticals, Inc. from 2002 to 2003.
Education includes undergraduate studies at Southern Polytechnic State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TERRASCEND CORP. 0,35 % | 30/06/2026 | 1 076 538 ( 0,35 % ) | 729 893 $ | 30/06/2026 |
HERON THERAPEUTICS INC 0,41 % | 19/07/2026 | 771 682 ( 0,41 % ) | 329 508 $ | 30/06/2026 |
Postes actifs de Craig Collard
| Sociétés | Poste | Début |
|---|---|---|
| TERRASCEND CORP. | Directeur/Membre du Conseil | 06/12/2018 |
| HERON THERAPEUTICS, INC. | Directeur Général | 03/04/2023 |
Cystic Fibrosis Foundation
 Cystic Fibrosis Foundation Miscellaneous Commercial ServicesCommercial Services Provides healthcare services and programs | Corporate Officer/Principal | - |
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Directeur/Membre du Conseil | - |
Hilltop Home Foundation
 Hilltop Home Foundation Hilltop Home Foundation is a private, nonprofit intermediate care facility with over 60 years of experience serving medically fragile children with severe to profound developmental disabilities. The private company is based in RALEIGH, NC. The facility supports up to 22 children, providing comprehensive, individualized, around-the-clock skilled nursing care by licensed professionals trained to manage complex health issues such as seizures, respiratory complications, and neuromuscular impairments. Hilltop Home Foundation offers a home-like environment emphasizing dignity, compassion, and safety, aiming to protect vulnerable children from abuse and neglect. The company's multidisciplinary care team includes executive and clinical directors, licensed nurses, dietitians, special education teachers, therapists, and support staff, ensuring continuity of care. The foundation provides a full range of personalized therapeutic services—including physical, occupational, speech, feeding, and respiratory therapies—designed to enhance mobility, communication, and overall quality of life. Educational services are delivered through a certified non-public school recognized by the North Carolina Department of Public Instruction, offering early intervention programs for children under five and partnering with Wake County Public Schools for older children. Certified special education teachers and assistants utilize assistive technology and language activities to foster communication, developmental progress, and confidence. Emergency medical care is accessible nearby, and the organization collaborates with community providers for additional psychological and nutritional support. | Directeur/Membre du Conseil | - |
Anciens postes connus de Craig Collard
| Sociétés | Poste | Fin |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Président | 02/03/2023 |
| SIERRA ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/07/2022 |
| VELOXIS PHARMACEUTICALS A/S | Directeur Général | 01/12/2021 |
Veloxis Pharmaceuticals, Inc.
 Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for kidney transplant patients | Directeur Général | 01/12/2021 |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Craig Collard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Health Technology |
Cornerstone BioPharma, Inc.
 Cornerstone BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceutical products for respiratory disorders | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for addictions and drug overdose | Health Technology |
Cornerstone Biopharma Holdings, Inc. | |
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Miscellaneous Commercial ServicesCommercial Services Provides healthcare services and programs | Commercial Services |
Southern Polytechnic State University
 Southern Polytechnic State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DJ Pharma, Inc. | |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
Carolina Pharmaceuticals, Inc. | |
Verum Pharmaceuticals, Inc. | |
Hilltop Home Foundation
Hilltop Home Foundation Hilltop Home Foundation is a private, nonprofit intermediate care facility with over 60 years of experience serving medically fragile children with severe to profound developmental disabilities. The private company is based in RALEIGH, NC. The facility supports up to 22 children, providing comprehensive, individualized, around-the-clock skilled nursing care by licensed professionals trained to manage complex health issues such as seizures, respiratory complications, and neuromuscular impairments. Hilltop Home Foundation offers a home-like environment emphasizing dignity, compassion, and safety, aiming to protect vulnerable children from abuse and neglect. The company's multidisciplinary care team includes executive and clinical directors, licensed nurses, dietitians, special education teachers, therapists, and support staff, ensuring continuity of care. The foundation provides a full range of personalized therapeutic services—including physical, occupational, speech, feeding, and respiratory therapies—designed to enhance mobility, communication, and overall quality of life. Educational services are delivered through a certified non-public school recognized by the North Carolina Department of Public Instruction, offering early intervention programs for children under five and partnering with Wake County Public Schools for older children. Certified special education teachers and assistants utilize assistive technology and language activities to foster communication, developmental progress, and confidence. Emergency medical care is accessible nearby, and the organization collaborates with community providers for additional psychological and nutritional support. | |
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for kidney transplant patients | Health Technology |
Terrascend Corp.
 Terrascend Corp. Agricultural Commodities/MillingProcess Industries Produces and sells medical cannabis products | Process Industries |
